Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Molecular Genetics and Metabolism|June 18, 2020
Laboratory monitoring of patients with hereditary tyrosinemia type IMatthew J Schultz, Brian C Netzel, Rani H Singh, et al.
Organic & Biomolecular Chemistry|May 19, 2025
Rhodium-catalyzed enantioselective hydrogenation of (1-arylvinyl)phosphonates with TADDOL-based phosphoramidite P,S ligandsVladislav S Zimarev, Ilya D Firsin, Alexander V Larin, et al.
Molecular Genetics and Metabolism|November 1, 2025
Clinical utility of untargeted urine oligosaccharide screeningGisele Bentz Pino, Marie A Quade, Matthew J Schultz, et al.
Organic & Biomolecular Chemistry|December 19, 2023
TADDOL-based <i>P</i>,<i>S</i>-bidentate phosphoramidite ligands in palladium-catalyzed asymmetric allylic substitutionKonstantin N Gavrilov, Ilya V Chuchelkin, Ilya D Firsin, et al.
Organic & Biomolecular Chemistry|July 24, 2024
Application of mixed phosphorus/sulfur ligands based on terpenoids in Pd-catalyzed asymmetric allylic substitution and Rh-catalyzed hydrogenationKonstantin N Gavrilov, Ilya V Chuchelkin, Vladislav K Gavrilov, et al.
JIMD Reports|July 14, 2021
The low excretor phenotype of glutaric acidemia type I is a source of false negative newborn screening results and challenging diagnosesAdam J Guenzel, Patricia L Hall, Anna I Scott, et al.
The Journal of Pediatrics|April 17, 2010
Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometrySilvia Tortorelli, Coleman T Turgeon, James S Lim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 14, 2025
Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe diseaseIbrahim T Khoja, Dawn S Peck, Dimitar K Gavrilov, et al.
Dalton Transactions (Cambridge, England : 2003)|April 15, 2020
Diamidophosphites from β-hydroxyamides: readily assembled ligands for Pd-catalyzed asymmetric allylic substitutionIlya V Chuchelkin, Konstantin N Gavrilov, Nataliya E Borisova, et al.
American Journal of Medical Genetics. Part A|October 12, 2020
Immune dysfunction in MGAT2-CDG: A clinical report and review of the literatureSheri A Poskanzer, Matthew J Schultz, Coleman T Turgeon, et al.
Pageof 6